| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
group | 0.100 | None | 1.000 | 22 | 0 | 2002 | 2019 | ||||||||
|
interleukin 10 receptor subunit alpha | 0.579 | 0.692 | 1.8E-02 |
|
group | 0.400 | strong | 1.000 | 21 | 1 | 2012 | 2019 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
group | 0.100 | None | 0.950 | 20 | 0 | 1993 | 2019 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
group | 0.100 | None | 0.950 | 20 | 0 | 1995 | 2019 | ||||||||
|
inflammatory bowel disease 5 | 0.705 | 0.538 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 2003 | 2012 | |||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
group | 0.400 | None | 1.000 | 19 | 3 | 1995 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
group | 0.100 | None | 1.000 | 19 | 0 | 1994 | 2019 | ||||||||
|
nucleotide binding oligomerization domain containing 1 | 0.541 | 0.769 | 2.5E-18 |
|
group | 0.100 | None | 0.944 | 18 | 2 | 2003 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 18 | 0 | 1998 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
group | 0.200 | None | 1.000 | 17 | 1 | 2000 | 2018 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
group | 0.300 | None | 0.941 | 17 | 0 | 1993 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.100 | None | 0.941 | 17 | 2 | 1999 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 2 | 0.538 | 0.692 | 1.00 |
|
group | 0.200 | None | 0.941 | 17 | 3 | 2011 | 2018 | ||||||||
|
solute carrier family 22 member 4 | 0.603 | 0.769 | 1.8E-08 |
|
group | 0.200 | None | 0.941 | 17 | 3 | 2005 | 2018 | ||||||||
|
interleukin 33 | 0.409 | 0.885 | 8.3E-10 |
|
group | 0.100 | None | 0.941 | 17 | 0 | 2010 | 2020 | ||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
group | 0.500 | None | 1.000 | 16 | 3 | 2008 | 2017 | |||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
group | 0.100 | None | 1.000 | 16 | 1 | 1994 | 2019 | ||||||||
|
caspase recruitment domain family member 9 | 0.566 | 0.654 | 8.1E-13 |
|
group | 0.500 | None | 0.938 | 16 | 2 | 2009 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.400 | None | 1.000 | 16 | 1 | 2001 | 2020 | ||||||||
|
interleukin 37 | 0.459 | 0.846 | 1.2E-04 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2007 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2001 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
group | 0.400 | None | 0.714 | 14 | 1 | 2005 | 2019 | ||||||||
|
inflammatory bowel disease 2 | 0.805 | 0.154 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 1998 | 2012 | |||||||||
|
inosine triphosphatase | 0.604 | 0.500 | 1.0E-07 |
|
group | 0.100 | None | 1.000 | 14 | 1 | 2004 | 2018 | ||||||||
|
myosin IXB | 0.644 | 0.615 | 1.00 |
|
group | 0.100 | None | 0.857 | 14 | 5 | 2006 | 2016 |